Office Research IN Clinical Amplifiction
Country not established
- Devices
- 1
What Office Research IN Clinical Amplifiction makes
Office Research produces rechargeable and non-rechargeable hearing aids designed for clinical amplification, including the WIDEXLINK IN CLEAR series, which are intended for use in audiological settings.
The company’s portfolio is regulated under FDA’s Class II device classification, with products authorised via the 510(k) pathway. The manufacturer is based in the United States.
Catalogue
Widexlink In Clear Series Hearing Aids Ref DEN100025
Regimes: De Novo Registry: De Novo
Frequently asked questions
How many devices does Office Research IN Clinical Amplifiction have in the registry?
The registry currently lists 1 device for Office Research IN Clinical Amplifiction. Devices recorded under merged duplicate company entries are counted once.
Which registries list Office Research IN Clinical Amplifiction's devices?
Among its 1 most recently registered device, Office Research IN Clinical Amplifiction has devices listed in FDA 510(k) (1 device).
What risk classes do Office Research IN Clinical Amplifiction's devices fall under?
Among its 1 most recently registered device, the classes recorded for Office Research IN Clinical Amplifiction's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Office Research IN Clinical Amplifiction in the registry?
The most recently registered devices listed for Office Research IN Clinical Amplifiction include WIDEXLINK IN CLEAR SERIES HEARING AIDS.